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Summary
 
Viral infections often induce potent CD8 T cell responses that play a key role in antiviral im-
munity. After viral clearance, the vast majority of the expanded CD8 T cells undergo apopto-
sis, leaving behind a stable number of memory cells. The relationship between the CD8 T cells
that clear the acute viral infection and the long-lived CD8 memory pool remaining in the indi-
vidual is not fully understood. To address this issue, we examined the T cell receptor (TCR)
repertoire of virus-specific CD8 T cells in the mouse model of infection with lymphocytic
choriomeningitis virus (LCMV) using three approaches: (
 
a
 
) in vivo quantitative TCR 
 
b
 
 chain
V segment and complementarity determining region 3 (CDR3) length repertoire analysis by
spectratyping (immunoscope); (
 
b
 
) identification of LCMV-specific CD8 T cells with MHC
class I tetramers containing viral peptide and costaining with TCR V
 
b
 
–specific antibodies; and
(
 
c
 
) functional TCR fingerprinting based on recognition of variant peptides. We compared the
repertoire of CD8 T cells responding to acute primary and secondary LCMV infections, to-
gether with that of virus-specific memory T cells in immune mice. Our analysis showed that
CD8 T cells from several V
 
b
 
 families participated in the anti-LCMV response directed to the
dominant cytotoxic T lymphocyte (CTL) epitope (NP118–126). However, the bulk (
 
z
 
70%) of
this CTL response was due to three privileged T cell populations systematically expanding during
LCMV infection. Approximately 30% of the response consisted of V
 
b
 
10
 
1
 
 CD8 T cells with a
 
b
 
 chain CDR3 length of nine amino acids, and 40% consisted of V
 
b
 
8.1
 
1
 
 (
 
b
 
 CDR3 
 
5 
 
eight amino
acids) and V
 
b
 
8.2
 
1
 
 cells (
 
b
 
 CDR3 
 
5 
 
six amino acids). Finally, we showed that the TCR reper-
toire of the primary antiviral CD8 T cell response was similar both structurally and functionally
to that of the memory pool and the secondary CD8 T cell effectors. These results suggest a sto-
chastic selection of memory cells from the pool of CD8 T cells activated during primary infection.
Key words: immunological memory • CD8 T cells • viral immunity • T cell receptor • 
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C
 
D8
 
1
 
 T cells play a key role in the control and clear-
ance of viral infections, and contribute to antiviral im-
munological memory (1). These lymphocytes recognize vi-
ral antigens presented in the context of self MHC class I
molecules at the surface of infected cells. The T cell antigen
receptor (TCR) is a membrane-bound heterodimer com-
posed of 
 
a
 
 and 
 
b
 
 chains. Each chain is encoded by a series
of rearranged segments termed variable (V),
 
1
 
 diversity (D),
joining (J), and constant (C) (2, 3). The broad diversity of
the TCR repertoire results from the numerous possible
V-D-J (or V-J in 
 
a
 
 chains) combinations, from random
mutations or nucleotide additions at the D-J and V-D (or
V-J in 
 
a
 
 chains) junctions, and from the random pairing of
separately recombined 
 
a
 
 and 
 
b
 
 chains. As in Igs, the most
diverse portion of the TCR is the CDR3 of the 
 
b
 
 chain,
which encompasses the V-D-J junctional area. It has been
proposed (4–6) that this loop makes direct contacts with
the peptide–MHC complex, and recent crystallographic
studies support this notion (7). The length of the CDR3
has been shown to be a major determinant of antigen rec-
ognition (8–10), suggesting that the loop length influences
 
1
 
Abbreviations used in this paper:
 
 C, constant; D, diversity; ELISPOT, en-
zyme-linked immunospot; J, joining; LCMV, lymphocytic choriomenin-
gitis virus; LDA, limiting dilution assay; PCC, pigeon cytochrome C; V,
variable.
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the docking of the TCR with its ligand. Due to the broad
diversity in the TCR repertoire, only a subset of all avail-
able T cells can recognize one given epitope. Direct exam-
ination of the TCR enables antigen-specific cells to be
identified and tracked during immunization or infections.
TCR usage also acts as a signature of the ongoing immune
response and can be used to compare different expanding T
cell subsets. For instance, comparative study of the primary
antiviral T cell response and memory pool can be accom-
plished by TCR repertoire analysis.
The TCR repertoire of antiviral CTL responses has been
studied for various systems in humans (8, 11–13), monkeys
(14), and mice (15–24). Some of these analyses concluded
or suggested that a limited subset of V segments are used by
the CTLs responding to a given epitope. Conversely, other
studies reported a broad TCR repertoire in the antiviral
CTL response they analyzed (20, 21). Lymphocytic chorio-
meningitis virus (LCMV) infections in mice give rise to
substantial CD8 T cell expansions, and at the peak of the
response, 
 
.
 
50% of the CD8 T cells are LCMV-specific
(25). The TCR repertoire of the CTL response to LCMV
infections has been studied for two different mouse strains.
In C57BL/6 mice, TCR sequence of a few clones directed
to one viral epitope (GP276–286) suggested usage of a lim-
ited number of V segments (16, 17). In BALB/c mice,
where the CTL response is essentially directed against a sin-
gle immunodominant L
 
d
 
-restricted epitope (26), one study
(21) reported isolation of three clones each using differ-
ent V segment combinations: V
 
a
 
1/V
 
b
 
10, V
 
a
 
3/V
 
b
 
6, and
V
 
a
 
2/V
 
b
 
7. The report concluded that there was marked
diversity in the responding TCR repertoire. However, all
of these analyses, like most studies of the TCR repertoire
in antiviral CTL responses, relied on isolation and in vitro
expansion of lymphocytes, a step prone to introduce im-
portant biases in the TCR usage (27–30).
The T cell response to LCMV infection of mice occurs
in three phases. First, there is a massive expansion of CD8
 
1
 
T cells, with maximal numbers apparent at day 8 after in-
fection. Second, a substantial decline of this population oc-
curs, and 
 
.
 
90% of the responding cells undergo apoptosis
between days 8 and 30; and third, there is a period of long-
term memory, with a stable number of memory CD8 T
cells persisting for the life of the mouse (1, 31). Secondary
infection of LCMV-immune mice results in rapid expan-
sion of CTL effectors from the memory pool. These CD8
T cells expedite viral clearance and are the mediators of the
protective immunity (1, 31). The links between the CD8
effector population at the peak of the primary response and
the memory pool residing in the individual after viral clear-
ance are not fully understood. One way to examine the re-
lationship between primary effectors and memory cells, or
between memory cells and secondary effectors, is to moni-
tor their clonotypic composition by TCR repertoire analy-
sis. Comparative study of TCR usage provides direct in-
sight into the selection processes shaping T cell memory
and anamnestic responses. These issues have been partially
addressed in various systems. The CD8 T cell response to
 
Listeria monocytogenes
 
 infection in mice was examined by
functional TCR fingerprinting (32). That study found that
TCR usage for one epitope was similar among primary ef-
fectors, memory T cell pool, and secondary effectors based
on recognition patterns of alanine-substituted peptides.
The T cell selection mechanisms have also been examined
in the response to pigeon cytochrome C (PCC) and HLA-
Cw3 (9, 10). McHeyzer-Williams and Davis (9) reported
TCR repertoire narrowing in the secondary CD4 T cell
response to PCC compared with the primary response,
whereas Maryanski et al. (10) found no difference between
the primary and secondary CD8 T cell responses to mouse
tumor cell lines expressing HLA-Cw3.
In this study, the TCR repertoire of the CTL response
to LCMV infection in BALB/c mice was examined di-
rectly by analysis of V
 
b
 
 segment and CDR3 length distri-
bution without any in vitro cell manipulation. We found
systematic expansion of three subsets of T cells. We
showed that these subsets were antigen-specific, as assayed
by surface staining with soluble tetrameric MHC–peptide
complexes, intracellular staining for IFN-
 
g
 
, and functional
assays on sorted cells. The three privileged T cell popula-
tions expanding upon infection were shown to account for
70% of the total LCMV-specific CD8
 
1
 
 T cells. The reper-
toire of acute primary effectors proved to be structurally
and functionally similar to that of the memory pool re-
maining in the individual after viral clearance, and to the
TCR repertoire of secondary effectors triggered by reinfec-
tion with LCMV. The implications of the magnitude and
the kinetics of expansion and decline of these virus-specific
T cell populations, as well as their role in immunological
memory, are discussed.
 
Materials and Methods
 
Virus Infection and Mice.
 
6–8-wk-old female BALB/c mice
were purchased from The Jackson Laboratory (Bar Harbor, ME).
Mice were infected intraperitoneally with 2 
 
3
 
 10
 
5
 
 PFU of
LCMV Armstrong and were used at indicated time points. For
secondary rechallenge experiments, immune mice were injected
intravenously with 2 
 
3 
 
10
 
6
 
 PFU of LCMV clone 13. Virus stocks
were grown and quantitated as described previously (33).
 
Flow Cytometry and FACS
 
Ò
 
 Analysis.
 
All the antibodies used
in this study were purchased from PharMingen (San Diego, CA).
Single cell suspensions of spleen were prepared, and 10
 
6
 
 cells were
stained in PBS containing 1% BSA and 0.02% sodium azide (FACS
 
Ò
 
buffer) for 30 min at 4
 
8
 
C followed by three washes in FACS
 
Ò
 
buffer. Samples were acquired on either a FACScan
 
Ò
 
 flow cytometer
or FACSCalibur
 
Ò
 
 instrument (Becton Dickinson, San Jose, CA).
For sorting purposes, 3 
 
3
 
 10
 
8
 
 cells were incubated in 5 ml
with 60 
 
m
 
g of anti-CD8 and anti-V
 
b
 
10 antibodies for 30 min at
4
 
8
 
C in RPMI 1640 medium supplemented with 10% FCS. The
cells were then washed once in the same buffer and processed im-
mediately on a FACSVantage
 
Ò
 
 sorter (Becton Dickinson). All
data were analyzed using CellQuest software (Becton Dickinson).
 
Intracellular IFN-
 
g
 
 Stain.
 
Spleen cells were cultured for 5 h in
complete medium supplemented with 50 U/ml human recombi-
nant IL-2 and 1 
 
m
 
l/ml Brefeldin A (Golgistop
 
TM
 
; PharMingen)
either in the presence or absence of CTL epitope peptides. The
peptides were used at a concentration of 0.1 
 
m
 
g/ml. The cells
were first surface-stained, then washed and subjected to intracel- 
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lular cytokine stain using the Cytofix/Cytoperm kit in accor-
dance with the manufacturer’s recommendations (PharMingen).
For intracellular IFN-
 
g
 
 stain, we used FITC-conjugated rat anti–
mouse IFN-
 
g
 
 mAb (clone XMG 1.2) and its isotype control Ab
(rat IgG1; both from PharMingen).
In experiments analyzing IFN-
 
g
 
 production and TCR V
 
b
 
 us-
age (see Fig. 5) after stimulation with specific peptide, there was
substantial downregulation of the TCR. Because of this TCR
downregulation, the staining pattern of antigen-specific CD8 T
cells was not clearly defined. For better staining of the activated
CD8 T cells, we used a high concentration of biotinylated anti-
V
 
b
 
8.1–8.2 or -V
 
b
 
10 Ab (4 
 
m
 
g per 10
 
6
 
 cells in 100 
 
m
 
l vol) and
subsequently added Cy-chrome–coupled streptavidin (Phar-
Mingen) to further amplify the signal.
 
Enzyme-linked Immunospot Assay for IFN-
 
g
 
–secreting Cells.
 
The
enzyme-linked immunospot (ELISPOT) assays were performed as
described by Murali-Krishna et al. (25) and Taguchi et al. (34). In
brief, 96-well filtration plates (Millipore Corp., Bedford, MA)
were coated with rat anti–mouse IFN-
 
g
 
 Ab (clone R4-6A2;
PharMingen), and responder cells were added into the wells
along with 5 
 
3 
 
10
 
5
 
 
 
g
 
-irradiated syngeneic feeder cells. Cells were
incubated for 36 h either in the presence or absence of peptide
stimulation (0.1 
 
m
 
g peptide/ml). The amino acid sequences of
peptides used have been described (35, 36). After the culture,
plates were washed followed by incubation with biotinylated
anti–mouse IFN-
 
g
 
 Ab (clone XMG 1.2; PharMingen). Spots
were developed using freshly prepared substrate buffer (0.03%
[wt/vol] 3-amino-9-ethyl-carbazole, 0.015% [vol/vol] H
 
2
 
0
 
2
 
 in
0.1 M sodium acetate, pH 5). Using this assay, we could accu-
rately measure a minimum of 10 spots in 10
 
6
 
 responder cells.
 
Preparation of H-2L
 
d
 
 Tetramers.
 
H2-L
 
d
 
 tetramers were pre-
pared as described by Murali-Krishna et al. (25). In brief, bacterial
expression of L
 
d
 
 and human b2-microglobulin was driven from
pET23-Ld-BSP and pHN1-b2m vectors in Escherichia coli strain
BL21(DE3). Folding was performed in the presence of NP118–
126 peptide. Purification by ionic exchange was followed by in
vitro biotinylation using purified BirA enzyme. Tetramers were
assembled by mixing biotinylated Ld-NP118–126 monomeric
complexes with fluorophore-conjugated avidin.
Ex Vivo CTL Assay and Limiting Dilution Assay. Cytotoxic ac-
tivity was tested in a standard 6-h 51Cr-release assay as described
previously (33). Targets were coated with peptide at a concentra-
tion of 0.1 mg/ml. Limiting dilution analysis (LDA) was per-
formed as described previously (31, 35).
Immunoscope Analysis. Immunoscope analyses were performed
as described by Pannetier et al. (37, 38). In brief, single cell sus-
pensions of individual spleens were prepared, and total RNA was
extracted. The cDNA synthesis was primed with a (dT)15 oligo-
nucleotide. An array of 24 PCR reactions was then performed
with oligonucleotide Cb2 (GCCAGAAGGTAGCAGAGACCC)
and 24 unique Vb-specific primers (see reference 37 for sequences).
Then 24 run-off reactions were done using fluorescent primer
Cb59 (CTTGGGTGGAGTCACATTTCTC). After analysis on
an automated sequencer (model 377; Applied Biosystems, Inc.,
Foster City, CA), the repertoire profile (i.e., the distribution of
the b chains in the various CDR3 lengths for each Vb) was cal-
culated with Immunoscope version 1.0 software (38).
Results
Immunoscope Analysis Reveals Three Privileged Responses to
LCMV Involving Vb101, Vb8.11, and Vb8.21 T Cells.
During the course of an acute LCMV infection in BALB/c
mice, the total number of activated CD81 splenocytes in-
creases dramatically (.10-fold) during the first 8 d, then
declines to reach a stable level after an additional 2–4 wk
(25, 31, 39). To identify these T cells expanding in re-
sponse to LCMV, we performed a quantitative in vivo
TCR repertoire analysis. We used the immunoscope ap-
proach (also referred to as “spectratyping”; references 30,
37, 38, and 40–45). With this technique, the TCR reper-
toire can be broken down into 21 subrepertoires (one for
each functional Vb segment [37]), which are analyzed indi-
vidually. The CDR3 length profiles of all functional TCR
Vb genes are determined by specific reverse transcription
PCR. For each of these segments, the profile acts as a den-
sity function or a histogram, giving the relative abundance
in vivo of T cells using each possible CDR3 length. With
this compartmentalized approach, immune responses are
monitored by the CDR3 profile changes they induce in
each Vb subrepertoire. Variations in the profiles result
from oligoclonal expansion or deletion of T cells using par-
ticular Vb/CDR3 length combinations.
With this approach, we compared the TCR repertoires
of naive mice and mice at the peak of an acute LCMV in-
fection. Total splenocytes were harvested from naive
BALB/c mice and from animals at day 8 after LCMV
infection. Previous studies (37) have shown that in naive
mice of various strains, the profiles show successive peaks
separated by three bases (i.e., one codon). The heights of
these peaks follow Gaussian-like curves centered on an av-
erage CDR3 length specific for each Vb segment. As ex-
pected from these previous studies, we observed such
shapes for the CDR3 length profiles in the naive BALB/c
TCR repertoire (Fig. 1). At day 8 after LCMV infection,
the CDR3 profile of 18 out of the 21 Vb subrepertoires re-
mained relatively unchanged as exemplified by the Vb4
profiles. In contrast, the CDR3 profiles of the remaining
three Vb segments showed very reproducible strong distor-
tions in all the LCMV-infected mice, a characteristic of
“public responses” (30, 45). As shown in Fig. 1, striking
public responses to LCMV in BALB/c mice occurred in
the Vb10, Vb8.1, and Vb8.2 subrepertoires. Each of these
three profiles showed expansion of T cell populations using
b chains of a privileged CDR3 length: Vb101, CDR3 5
nine amino acids; Vb8.1, CDR3 5 eight amino acids; and
Vb8.2, CDR3 5 six amino acids. At day 8 after infection,
the area of the major expanded peaks (CDR3 lengths)
showed that these populations accounted for 50–70% of
the entire Vb10 subrepertoire, 30–40% of the Vb8.1 sub-
repertoire, and 20–30% of the Vb8.2 repertoire. This
highly reproducible feature prompted us to better charac-
terize both structurally and functionally these public im-
mune responses to LCMV infection.
Vb101CD81 and Vb8.1–8.21CD81 Cell Populations Par-
allel the Expansion and Decline of CD8 T Cells during the
Course of LCMV Infection. Using Vb-specific mAbs, we
followed Vb101 and Vb8.1–8.21 T cells by FACSÒ analy-
sis during the course of an acute LCMV infection in
BALB/c mice. Splenocytes were harvested at successive
time points after LCMV infection (days 3, 5, 8, 15, 39, 68,74 TCR Repertoire of Primary and Memory Antiviral T Cells
and 270 after infection) and surface-stained for CD8 or
CD4, and LFA1 (as an activation marker), as well as Vb10,
Vb8.1–8.2, or Vb4 (as a negative control). Since the
Vb10, Vb8.1, and Vb8.2 public responses were observed
on total splenocytes, the distortion of the CDR3 length
profiles could have been due to either or both CD41 and
CD81 T cell expansions. The surface stains showed that no
particular CD41Vb101 or CD41Vb8.1–8.21 T cell ex-
pansion occurred during the course of infection (data not
shown). However, as shown in Fig. 2, the CD81Vb101
and CD81Vb8.1–8.21 T cell populations increased dra-
matically during the first 8 d, then declined to reach stable
levels after 1 mo. Direct comparison of Fig. 2, A, C, and D
shows that the expansion and contraction of the total
CD81, Vb101CD81, and Vb8.1–8.21CD81 T cell popu-
lations followed parallel courses. The expansion was visible
as early as day 3 after infection. When it reached its peak at
day 8, the CD81Vb101 and CD81Vb8.1–8.21 T cell pop-
ulation numbers were 10- and 5-fold higher, respectively,
than in a naive BALB/c mouse. As expected from immu-
noscope analysis, where no public response was observed
such as for the Vb4 segment, FACSÒ analysis did not show
a substantial Vb41 T cell expansion (Fig. 2 B).
The activation status of the expanding cells was exam-
ined by staining for LFA1 (CD11a). Fig. 3 A shows that at
the peak of the response, .80% of the Vb101 and Vb8.1–
8.21CD81 T cells were activated. These numbers match
the proportions of expanded populations measured by im-
munoscope. Even in immune mice, there was a substantial
proportion of LFA1high cells among these two Vb families.
As a result, the CD81LFA1high lymphocyte pool was en-
riched in Vb101 and Vb8.1–8.21 T cells (Fig. 3 B).
Vb101 and Vb8.1–8.21 Cells Account for 70% of All
LCMV-specific CD81 T Cells. The fact that after LCMV
infection, the proportions of both Vb101 and Vb8.1–8.21
cells differ between activated and nonactivated CD81 pop-
ulations, together with the observed bias for particular
CDR3 lengths, imply that the T cell repertoire differs be-
tween the expanding activated and resting nonactivated
CD81 populations. This structural feature could be due to
the selective growth of T cells specific for LCMV. To test
this hypothesis, we examined the specificity of the expand-
ing cells with several structural and functional assays.
The CD81 response of BALB/c mice to acute LCMV
infection is almost entirely (i.e., .96% of the CD81 T
cells) directed towards the NP118–126 immunodominant
Figure 1. Profiles of the Vb10, Vb8.1,
Vb8.2, and Vb4 subrepertoires in spleen cells
from naive and LCMV-infected (day 8) BALB/c
mice.  x-axis, Lengths in amino acids of the
CDR3 regions; y-axis, fluorescence intensities,
reflecting the number of clones using each Vb/
CDR3 length combination. Each plot is nor-
malized; therefore, the unit of the ordinate is
arbitrary. Arrows, Position of the major public
responses.
Figure 2. Kinetics of CD81 T cell expansion
and decline. Quantitation of total CD81 ( A ),
Vb41CD81 (B), Vb101CD81 (C), or Vb8.1–
8.21CD81 ( D ) cells in the spleen during the
course of acute LCMV infection. Each point
represents an individual mouse.75 Sourdive et al.
epitope presented by the Ld molecule (25, 26). We took
advantage of this feature to identify virus-specific T cells by
staining with Ld-NP118–126 MHC class I tetramers (25,
46). Splenocytes were harvested from naive and LCMV-
infected BALB/c mice, and stained with CD8 and TCR
Vb–specific antibodies together with Ld-NP118–126 tet-
ramers. Examples of these costains are shown in Fig. 4 A.
At the peak of the response, 50–55% of the total CD81 T
cells recognized the immunodominant NP118–126 epitope.
The overall Vb usage in the repertoire of the NP118–126-
specific pool is summarized in Fig. 4 B and compared with
the Vb usage in the non-antigen–specific CD81 pool in
acute mice or in the CD81 population of a naive mouse.
While the non-LCMV–specific CD81 repertoire was simi-
lar to that of a naive mouse, the Vb usage of the CD81 T
cells binding to Ld-NP118–126 tetramers was strongly bi-
ased. At the peak of the response, the spleen contained
z2.4 3 107 CD81 lymphocytes. Therefore, z1.3 3 107
cells were LCMV NP118–126-specific, of which 30% (3.9 3
106 cells) were Vb101 and almost 40% (5.2 3 106 cells)
were Vb8.1–8.21 (Fig. 4, A and B). Thus, the bulk of the
response at day 8 after infection used only three different
Vb segments. Therefore, the TCR repertoire in the
LCMV-specific population was narrow relative to the non-
antigen–specific CD81 pool in the same animals. More-
over, z60% of all CD81Vb8.1–8.21 cells and 85% of all
Vb101CD81 lymphocytes were directed against NP118–
126 (Fig. 4 A). This frequency matches the magnitude of
the massive public responses within these Vb subreper-
toires observed by CDR3 length profile analysis.
To confirm our analysis of Vb usage in the response to
the single immunodominant NP118–126 epitope, we used
a functional assay for antigen specificity. Detection of IFN-g
secretion upon specific antigenic stimulation was per-
formed by anticytokine intracellular staining at day 8 after
LCMV infection. Once harvested, the splenocytes were
stimulated in vitro for 5 h in the presence or absence of
NP118–126 peptide. The cells were subsequently surface-
stained for CD8 and Vb10 or Vb8.1–8.2, and intracellular
stain for IFN-g was then performed. Fig. 5 shows that 74%
of the Vb101CD81 cells and 55% of the Vb8.1–8.21CD81
cells responded to 5 h of stimulation with NP118–126 by
secreting IFN-g and downregulating TCR levels. In this
functional assay, Vb101CD81 and Vb8.1–8.21CD81 cells
accounted for 32 and 36%, respectively, of the total anti-
LCMV CD8 response. These figures match the proportions
obtained by flow cytometry on cells stained with Ld-NP118–
126 tetramers.
To further confirm the massive anti-LCMV CD81 re-
sponse in the Vb101 subrepertoire, we performed func-
tional assays on sorted Vb101CD81 and Vb102CD81
populations. 6-wk-old BALB/c mice were infected with
LCMV and killed at day 8 after infection. Splenocytes were
harvested, pooled, and surface-stained for CD8 and Vb10.
The Vb101CD81 and Vb102CD81 populations were
then sorted, and were found to be 91 and 99% pure, re-
spectively, after sorting. For each sorted population, as well
as unsorted total splenocytes, the frequency of cells produc-
ing IFN-g after stimulation by the NP118–126 peptide was
measured by ELISPOT assay. As shown in Fig. 6 A, at day
8 after LCMV infection, .60% of the Vb101CD81 lym-
phocytes secreted IFN-g after stimulation with NP118–
126 peptide. The frequency of NP118–126-specific T cells
was z2.5 times lower in the Vb102CD81 population. We
also performed an LDA on these two sorted cell popula-
tions to measure the frequency of NP118–126-specific
CTL precursors. As shown in Fig. 6 C, the frequency was
about fourfold higher in the Vb101CD81 population than
Figure 3. Activation status of Vb101 and Vb8.1–8.21 cells in naive, acute (day 8 after infection), and immune (.day 38 after infection) mice. (A)
LFA1 analyses of CD81Vb101 or CD81Vb8.1–8.21 gated cells. All numbers are in percentage of gated cells. (B) Comparison of the frequencies of
Vb101 and Vb8.1–8.21 cells among CD81LFA1high and CD81LFA1low cells. White bars, Naive; black bars, acute; striped bars, immune. The values plotted
are averages 6 SEs calculated from seven mice.76 TCR Repertoire of Primary and Memory Antiviral T Cells
in the Vb102CD81 population, a ratio consistent with the
cytokine ELISPOT data (Fig. 6 A).
Although the CD81 response to LCMV in BALB/c
mice is essentially directed against NP118–126, a response
to the Kd-restricted subdominant GP283–292 epitope can
also be detected at day 8 after infection, yet at a far lower
level (,1% of the total antiviral response; references 35 and
36). We used this feature of the BALB/c immune response
as a control in our functional characterization of Vb101
CD81 and Vb102CD81 isolated populations. As shown in
Fig. 6 B, all of the GP283–292-specific cells were found
among Vb102CD81 splenocytes. This result shows that
while highly responsive to the Ld-restricted NP118–126
stimulus, the Vb101CD81 population is ignorant of the
Kd-restricted GP283–292 subdominant epitope.
These functional assays on sorted cells, together with the
MHC class I tetramer staining and the intracellular staining
for IFN-g, all show that most of the Vb101CD81 T and a
majority of the Vb8.1–8.21CD81 cells were functionally
specific for the NP118–126 immunodominant peptide.
Conserved TCR Usage among Primary, Memory, and Sec-
ondary CD81 T Cell Responses to LCMV. TCR repertoire
analysis provided us with a means to monitor LCMV-spe-
cific T cells in BALB/c mice. Having used it to analyze the
primary CD81 T cell response to LCMV, we applied this
approach to characterize virus-specific T cells in the mem-
ory pool. Splenocytes from LCMV-immune mice (be-
tween days 39 and 68 after infection) were stained with Ld-
NP118–126 tetramers to identify antigen-specific cells and
costained with CD8 and a panel of Vb-specific antibodies.
The results of these analyses are summarized in Fig. 7 B,
and representative FACSÒ profiles for selected Vb families
are shown in Fig. 7 A. The TCR usage of NP118–126-
specific CD81 T cells in immune mice was strikingly simi-
lar to the pattern seen during the primary response (day 8).
Vb8.1–8.21 and Vb101 cells again accounted for the ma-
jority of LCMV-specific memory CD81 T cells, and the
overall hierarchy of TCR usage of memory CD81 T cells
was similar to the effector population at day 8 (Fig. 7 B).
Since the absolute numbers of NP118–126-specific CD81
T cells in immune mice was z10-fold lower than the
numbers at the peak of the primary response, the results in
Fig. 7 show that TCR usage did not play a major role in
determining which LCMV-specific CD81 T cells died and
which survived to go into the memory pool.
We next examined the TCR usage of LCMV-specific
CD81 T cells during a secondary response. Immune mice
Figure 4. TCR usage of LCMV NP118–126-specific CD8 T cells. (A)
Flow cytometry analyses of Ld-NP118–126 tetramer–stained cells. Spleen
cells from naive or LCMV acute mice (day 8) were stained with Ld-
NP118–126 tetramers, and antibodies to CD8 as well as to Vb4, Vb8.1–
8.2, or Vb10. FACSÒ events were gated on CD81 cells. All numbers are
in percentage of gated cells. (B) Summary of Vb usage among LCMV-
specific CD8 T cells (black bars), non-LCMV–specific CD8 T cells (striped
bars), and naive CD8 T cells (white bars). All values are expressed in per-
cent and are averaged from three to six mice.
Figure 5. Intracellular staining for IFN-g. Splenocytes from BALB/c
mice at day 8 after LCMV infection were incubated with or without
NP118–126 peptide and stained for CD8, Vb10, or Vb8.1–8.2 and intra-
cellular IFN-g. The panels show the Vb10 or Vb8.1–8.2 and intracellular
IFN-g analyses of gated CD81 cells. All numbers are in percentage of
gated cells.77 Sourdive et al.
were rechallenged with LCMV, and at the peak of the an-
amnestic response (day 5 after infection), in vivo TCR rep-
ertoire analysis was done by staining with Ld-NP118–126
tetramers and Vb-specific antibodies, and also by determin-
ing Vb/CDR3 length profiles by immunoscope. As shown
in Fig. 7, A and B, major expansions again occurred in
LCMV-specific CD81 T cells expressing Vb10 or Vb8.1–
8.2. The overall TCR usage of the virus-specific secondary
response was similar to the primary response and the mem-
ory T cell pool. Moreover, the CDR3 length analysis (Fig.
8) showed, as in the primary infection, that three striking
oligoclonal responses were apparent: Vb101, CDR3 5
nine amino acids; Vb8.1, CDR3 5 eight amino acids; and
Vb8.2, CDR3 5 six amino acids. Also, similar to the pri-
mary response, only limited distortions of the CDR3
length profile were observed for the other Vb segments, as
exemplified by the profile for Vb4 (Fig. 8).
The above data provided structural evidence that LCMV-
specific primary, memory, and secondary CD81 T cell
responses were similar. We also needed some functional
confirmation that the LCMV-specific T cell repertoire com-
prised similar subsets of clones during the acute primary re-
sponse, in the T cell memory pool remaining after viral
clearance, and during secondary infection. To this end, we
examined the TCR functional fingerprints of these three T
cell populations by variant peptide analysis. In this ap-
proach, single point mutations are introduced in the
epitope, and their impact on T cell recognition is measured
by functional assays (32, 47–49). Variant peptides derived
from the wild-type LCMV NP118–126 sequence (RPQA-
SGVYM) were synthesized with single amino acid substi-
tutions. All positions but the two known anchor residues
(positions 2 and 9) were tested. Mutations in positions 3, 5,
6, and 8 appeared to affect TCR contact without abolish-
ing the binding of the peptide to Ld (data not shown). A set
of mutant peptides was used to stimulate splenocytes from
acute, immune, or rechallenged mice. The cells were then
stained for surface markers CD8, Vb10, and Vb8.1–8.2 as
well as intracellular IFN-g. Since the substituted peptides
retain substantial affinity for Ld, the variations in T cell acti-
vation, as measured by IFN-g secretion, reflect the impact
of each mutation on TCR recognition. Fig. 9 A shows the
compilation of these measurements for total CD81 T cells.
The fingerprints obtained by intracellular staining for IFN-g
were similar between primary effectors and memory cells.
The profile also remained comparable for secondary effec-
tors. As a control, standard cytolytic assays were used for
primary and secondary effectors to verify that the mutations
affected cytotoxicity to the same extent as IFN-g secretion
(data not shown). Fig. 9, B and C, shows fingerprint analy-
ses of CD81 T cells expressing Vb10 or Vb8.1–8.2. Com-
parison of the fingerprints of the NP118–126-specific
Vb101 and Vb8.1–8.21 populations within any individual
mouse showed that although comparable, the fingerprints
of these two populations were not identical. Whenever a
Figure 6. Functional analyses
of sorted Vb101CD81 and
Vb102CD81 cells. IFN-g
ELISPOT assays measuring the
frequencies of LCMV-specific T
cells in the unsorted or sorted
populations. (A) Frequencies of
NP118–126-specific cells. (B) Fre-
quencies of GP283–292-specific
T cells. (C) LDA of NP118–126-
specific CTL precursor in the un-
sorted or sorted populations.
Figure 7. TCR repertoire
analysis of LCMV-specific CD8
T cells in immune and rechal-
lenged mice. (A) Vb4, Vb10, or
Vb8.1–8.2 and Ld-NP118–126
analyses on gated CD81 T cells
from an LCMV-immune mouse
and an immune mouse 5 d after
rechallenge with LCMV. The
figures are in percentage of total
CD8 T cells. (B) Summary of
TCR Vb usage in acute, im-
mune, and rechallenged mice.
The values plotted are averaged
from three to six mice. The total
number of Ld-NP118–1261-spe-
cific cells per spleen was 11.1 3
106 6 2 3 106 in acute mice, 9.7
3 105 6 2 3 105 in immune
mice, and 5.1 3 106 6 0.8 3
106 in rechallenged mice.78 TCR Repertoire of Primary and Memory Antiviral T Cells
mutation inhibited TCR recognition, its effect was stron-
ger on Vb101CD81 cells than on Vb8.1–8.21 T lympho-
cytes. These different profiles for Vb101 and Vb8.1–8.21
validated our technical approach and confirmed that the in-
hibitory mutations on positions 3, 5, 6, and 8 were affect-
ing TCR contact residues. As shown in Fig. 9, B and C,
both for CD81Vb101 and CD81Vb8.1–8.21 populations,
the profiles were well conserved between the acute re-
sponse (top) and the memory pool (middle). These finger-
prints show that the memory pool remaining after viral
clearance is functionally similar to the primary CTL effec-
tor population. The fingerprints of the effectors during an-
amnestic response to reinfection (bottom) were also close to
those of acute primary T cell effectors or memory CD81 T
cell pool, although the impact of mutations in the NP118–
126 epitope seemed slightly stronger for the Vb101CD81
secondary response.
Discussion
In this report, we have structurally and functionally de-
fined the CD81 T cell populations responding to acute
LCMV infection in BALB/c mice. Our studies have clearly
shown that three oligoclonal populations comprise up to
70% of the CD81 T cell response to LCMV infection.
Moreover, by comparing the LCMV-specific T cell popu-
lation during primary infection, at the memory stage, and
during secondary reinfections, we have demonstrated that
the acute CD81 effector response and the memory T cell
pool use a similar TCR repertoire.
A Limited CD8 T Cell Repertoire Responds to Acute LCMV
Infection by Undergoing Massive Expansion. Combining sur-
face staining with fluorescent MHC–peptide tetramers and
the immunoscope approach, we quantitatively examined the
in vivo T cell immune response to LCMV infection in the
BALB/c mouse. Out of the 168 Vb segment/CDR3 length
possible combinations (45), three were used predominantly:
Vb101, CDR3 5 nine amino acids; Vb8.1, CDR3 5
eight amino acids; and Vb8.2, CDR3 5 six amino acids.
They accounted for 70% of the antiviral CTL response.
This high expansion of a few limited subsets of clones dis-
torted the responding CD81 T cell repertoire and nar-
rowed its complexity. Such predictable use of TCR seg-
ments by antigen-specific T cells has been observed in
other systems (30, 45) and termed “public response” by
analogy with true public B cell clones. However, several
analyses performed in mice (30, 50, 51) have shown that al-
though T cells involved in the same public response use the
Figure 8. Profiles of the Vb10, Vb8.1,
Vb8.2, and Vb4 subrepertoires in the secondary
response of BALB/c mice to LCMV. Top, Pro-
files at 125 d after LCMV infection. Bottom,
Profiles of an immune mouse at day 5 after re-
challenge with LCMV. x-axis, Lengths in amino
acids of the CDR3 regions; y-axis, fluorescence
intensities (reflecting the number of clones with
a particular CDR3 length using Vb10, Vb8.1,
Vb8.2, or Vb4). Arrows, Position of the major
public responses.
Figure 9. TCR functional fingerprinting of
LCMV NP118–126-specific CD8 T cells. TCR
fingerprints of total CD8 T cells (A),
Vb101CD81 (B), and Vb 8.1–8.21CD81 cells
(C). Primary effectors (top), memory T cells
(middle), or secondary effectors (bottom) were
tested for IFN-g secretion with variant peptides
derived from NP118–126. The number of IFN-
g–secreting cells seen after stimulation with
variant peptides was normalized to the number
obtained with the wild-type peptide (Wt) and is
expressed as percentage of wild-type response.
The data shown are representative of six experi-
ments.79 Sourdive et al.
same Vb segment and have identical b chain CDR3
lengths, they may use different a chains and also different
Jb and Db segments. Although variations in the V-D-J re-
combination processes probably lead to naive repertoires
that are not strictly identical from mouse to mouse, the fre-
quency of rearrangements coding for CDR3 peptidic se-
quences similar enough to be recruited in a particular pub-
lic response remains high. Preliminary results (D. Sourdive,
unpublished data) show that several different Jb segments
are used by the LCMV-specific Vb101CD81 as well as
Vb8.21CD81 T cells. Therefore, the CDR3 peptidic se-
quence of the responding cells is degenerated. We propose
that this relaxed sequence requirement for T cells using the
{Vb101, CDR3 5 9 amino acids}, {Vb8.1, CDR3 5 8
amino acids}, or {Vb8.2, CDR3 5 6 amino acids} combi-
nation allows any naive BALB/c mouse to have a large
pool of eligible LCMV-specific precursors in these three
subrepertoires. Therefore, the probability that some of
them will encounter the antigen during the infection is
very high, systematically leading to the three strong public
responses.
Horwitz et al. (21) reported three different TCR se-
quences used by T cell clones specific for the immu-
nodominant NP118–126 epitope. Interestingly, one of these
clones expresses Vb10 with a b chain CDR3 length of
nine amino acids, fitting one of the public responses we
observed in vivo. The two other clones characterized by
Horwitz et al. use the Vb6 and Vb7 segments that each
contribute 5–7% of the response in vivo (Fig. 4 B). It is
likely that the in vitro expansion and the substantial anti-
genic stimulation favored the isolation of these less frequent
LCMV-specific clones. Numerous studies have shown that
culturing lymphocytes in vitro may introduce drastic biases
in the composition of the resulting population (27–30).
Both our MHC–peptide tetramer–based flow cytometric
analysis and the direct quantitative reverse transcription
PCR analysis circumvent these in vitro biases (37, 38, 41,
44, 45).
Restricted T cell repertoires have been reported in other
viral systems, including influenza (11, 19, 52), EBV (53–
55), HSV1 (22, 24, 56), CMV (12, 15), simian immunode-
ficiency virus (14), HIV (8), hepatitis C virus (13, 57), and
enteric reovirus (23). Many of these viral infections elicit
responses to several immunodominant epitopes; however,
the TCR repertoire of each resulting response seems re-
stricted. Limited TCR complexity in the CD81 T cell pool
seems to be a conserved feature of acute responses to viral
infections. As reported here, this feature is also shared by
LCMV; therefore, it is probable that antiviral T cell re-
sponses in general are governed by comparable rules and
mechanisms.
The LCMV-specific Responses Leave Scars in the Immune T
Cell Repertoire. Our analyses showed that LCMV NP118–
126-specific CD81 T cells accounted for .10% of all
splenic CD81 T cells in immune mice (Fig. 7 A). Here
again, the vast majority of these cells express Vb10, Vb8.1,
or Vb8.2. This is corroborated by our kinetic analysis,
which shows an increase in Vb101CD81 and Vb8.1–8.21
lymphocytes in the activated CD8 T cell population that
remains after viral clearance. These 2.1 3 105 NP118–126-
specific Vb101CD81 and 3.9 3 105 Vb8.1–8.21CD81
T cells are large permanent “immunological scars” in the
TCR repertoire of the host, and reflect long-lasting NP118–
126-specific immunological memory (1). The systematic
occurrence of these scars makes them a tracer of past
LCMV infections in BALB/c mice. Studies performed both
in humans (58) and in mice (59) have shown that aged in-
dividuals accumulate expanded mono- or oligoclonal CD81
and CD41 T cell populations. Such oligoclonal populations
are especially seen among the CD81 T cell subset. Our
study provides a possible explanation for this phenomenon.
Throughout the life of the individual, encounters with an-
tigens leave long-lasting immunological scars. Systemic vi-
ral infections induce extensive CD8 T cell expansion in
vivo, and often this is due to extensive division of a limited
number of clones. The accumulation of such memory cell
populations with restricted TCR usage would thus shape
the T cell pools and result in highly biased TCR repertoires
in aged individuals, reflecting their immunological history.
The LCMV-specific TCR Repertoire Is Conserved between
Effectors and Memory Cells, Suggesting a Stochastic Selection of
CD81 Memory Cells from the T Cells Activated during Primary
Infection. Our study has shown that the TCR repertoire
of LCMV-specific memory cells in immune mice was sim-
ilar to that of the acute primary response based on staining
with Ld-NP118–126 tetramers and Vb antibodies. Also,
functional variant peptide analysis showed that the finger-
prints of NP118–126-specific Vb101CD81, Vb8.1–8.21
CD81, or total CD81 T cell were almost identical in the
primary response and in the memory pool, confirming that
the compositions of these LCMV-specific lymphocyte pop-
ulations were conserved. Since the response was highly re-
producible from mouse to mouse, these conclusions can be
made without longitudinal studies of individual mice over
time. It is well established that the majority of activated
CD81 T cells undergo apoptosis, and only a small fraction
of these lymphocytes survive to become memory cells (1).
The selection processes that determine which T cells sur-
vive and which ones die are not fully understood. Our re-
sults show that this selection is not Vb discriminant and
probably occurs stochastically in a TCR-independent manner.
The vast majority (.90%) of activated T cells die after
the viral infection has been resolved, i.e., under conditions
of limiting antigen. It has been proposed that T cells with
high affinity TCR would get an antigenic stimulus and sur-
vive, whereas the low affinity T cells would be unable to
compete for this limiting antigen and would die due to lack
of appropriate signaling through the TCR (49, 60). A pre-
diction of this model is that the TCR usage of memory T
cells would be different (i.e., narrower) from the antigen-
specific T cells activated during the primary response. Our
results do not support this model, and show that TCR us-
age does not play a role in determining which activated
CD81 lymphocytes undergo apoptosis and which ones sur-
vive to become memory T cells.
Our refined b chain CDR3 length analysis showed that80 TCR Repertoire of Primary and Memory Antiviral T Cells
the three dominant public responses (Vb10, Vb8.1, and
Vb8.2) detected in primary infections and maintained in
the memory pool again expanded to comprise .70% of the
secondary response upon rechallenge with LCMV. Also,
the proportions of the minor NP118–126-specific CD81 T
cell responses (Vb7, Vb13, Vb6, etc.) were similar be-
tween primary and secondary effectors. In addition, the
functional fingerprints of secondary effector populations re-
sembled that of the memory pool. This suggests that the
vast majority of the memory T cell pool was recruited to
clear these secondary infections. However, our analysis also
detected slight alterations in the secondary response to
LCMV. These were revealed by a stronger impact of in-
hibitory substitutions in the NP118–126 epitope on recog-
nition by the Vb101 subset. The Vb101 response seemed
slightly more specific of the NP118–126 wild-type se-
quence, suggesting that this subrepertoire might have be-
come somewhat focused upon rechallenge. Previous studies
have compared the TCR usage of primary and secondary T
cell responses in various systems. Although some studies on
CD81 responses reported only limited changes (10, 32,
44), others found reduction of the TCR repertoire of
CD41 (9, 61) or CD81 (49) responses leading to focusing
of the antigen-specific T cell subset. One of these studies
reported a maturation of the CD81 response to one of the
immunodominant epitopes in LCMV infection of C57BL/
6 mice (49). In that study, immune mice were challenged
with a low dose of the LCMV WE strain, which would
lead to a much lower antigenic load than the highly inva-
sive LCMV clone 13 strain we used. It is possible that the
extent of antigenic exposure during secondary response
plays a role in the recruitment of effectors from memory
cells. In our system, secondary responses had practically the
same magnitude as primary responses at their peak. The an-
tigenic exposure was high, leading to a broad recruitment
of T cells and a TCR repertoire similar to that of the mem-
ory pool. However, if the antigenic load upon reexposure
is low, only a subset of memory T cells (high affinity/avid-
ity ones) may participate in the secondary response. This
hypothesis (62) links the magnitude of the secondary re-
sponse to the antigen dose and the minimal antigen sensi-
tivity of the recruited T cells. We have shown that the
composition of the memory pool is similar to that of the
primary effector population. Therefore, we predict that,
more than the absolute size of the anamnestic response, it is
the ratio of its magnitude to that of the primary response
that determines the extent of recruitment among memory
T cells. If the sizes of the primary and secondary responses
are similar, it is likely that the TCR usage will be similar.
The memory T cell pool is a scar in the TCR repertoire of
the immune individual. Its composition is shaped both by
the antigen and the magnitude of the response to immuni-
zation. Therefore, it carries not only the memory of the
antigen but also the history of its encounter.
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